UNSPSC 51182038: Norethandrolone

This classification denotes a therapeutic androgen with the molecular formula C20H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P7W01638W6, chemically known as 19-nortestosterone, 17-ethyl- but generally known as norethandrolone, which bears US NIH Compound Identifier 5858. European Medicines Agency schedules Norethandrolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09361MIG.

UNSPSC 51182038 Norethandrolone, a Commodity code, covers synthetic anabolic steroid pharmaceuticals that state and local governments procure primarily through cooperative purchasing agreements for distribution across government healthcare facilities. State and local health departments, correctional systems, and public hospitals source norethandrolone and related generic multi-source pharmaceuticals via master agreements with authorized pharmaceutical wholesalers, paying a 3 percent administrative fee on contract purchases and complying with cGMP certification, FDA requirements, and Drug Supply Chain Security Act documentation. Soliciting bodies include state procurement offices administering cooperative purchasing vehicles on behalf of multiple jurisdictions, with participating states and localities leveraging shared contracts to negotiate volume pricing and standardize product specifications across their healthcare operations. Vendors must maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and support chargeback systems, EDI capabilities, and flexible pricing structures (flat price, net price formats, WAC-minus configurations).

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, establishing two-year contracts effective July 1, 2026 across participating states including Oregon. Evaluation weighted price competitiveness at 75 percent, with fixed pricing, administrative compliance, EDI capability, and fee acceptance accounting for the remaining 25 percent. Vendors must carry workers' compensation insurance, $5 million commercial general liability, $2 million network security and privacy liability, and $2 million professional liability, with products required to maintain at least one-year expiration dates and six-month minimum shelf life from manufacture. Performance penalties ranging from $200 to $1,500 apply for late reporting, missed onboarding timelines, and improper class-of-trade denials.